BASEIMMUNE LTD

THE LONDON BIOSCIENCE INNOVATION CENTRE, ROYAL COLLEGE STREET, LONDON  NW1 0NH
  • Active
  • Private Limited Company
  • Company No. 12289125
  • Last Updated: 01 Mar 2024

Company Profile

BASEIMMUNE LTD was incorporated on Wednesday, October 30, 2019 as a Private Limited Company with registered address in LONDON. BASEIMMUNE LTD has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 5 years 3 months and 26 days.

Name BASEIMMUNE LTD
Company number 12289125
Company type Private Limited Company
Incorporation date 30 Oct 2019
Status Active
Industry (SIC 2007)

Address

Registered Address THE LONDON BIOSCIENCE INNOVATION CENTRE
ROYAL COLLEGE STREET
LONDON
NW1 0NH
Country Of Origin ENGLAND

Map based on PostCode

Ownership Information

Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.

Name Nature of Control
Dr Ariane Karla Cruz Gomes Nationality: Brazilian Dates: Wednesday, October 30, 2019 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
Dr Joshua Miles Blight Nationality: British Dates: Wednesday, October 30, 2019 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
Ms Philip James Gordon Kemlo Nationality: British Dates: Wednesday, October 30, 2019 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors

Accounts and Confirmation

Type of accounts TOTAL EXEMPTION FULL
End of financial Year 31 October
Next annual accounts due 31 July 2024, (-209 days left)
Latest accounts 31 October 2022
Next confirmation statement due 27 November 2020
Last confirmation statement dated Not available

Mortgages

No mortgages have been registered against BASEIMMUNE LTD.

Previous Names

Name Change Date
BASEIMMUNE LTD 30 Oct 2019